Washington has the tools. It’s time to use them.
Economy
Reporting and analysis on the American economy and economic policy: how markets, monopolies, and public policy shape jobs, wages, and opportunity. Includes our long-running coverage of antitrust and corporate power in The Monopolized Economy.
The New Company Towns
Monopolistic hospital systems now dominate the economies of many cities—and shape public policy far beyond the scope of medicine.
Jake Sullivan on a New Economic Alliance
Biden’s national security adviser takes on old-style free trade agreements and makes the case for putting American economic security at the heart of American foreign policy.
Private Equity and Its Hospitals
“Safety net hospitals” serve troubled communities like Chester in Delaware County, Pennsylvania. Finance companies serve themselves.
How to Stop the Drug Companies from Hiking Prices for Covid Vaccines
The drug companies got rich during the pandemic through massive government subsidies. Now, they want to raise the price of lifesaving treatment. Fostering competition could keep costs down.
After the East Palestine, Ohio, Train Disaster, Why Approve More Rail Monopolies?
The accident highlights railroad consolidation just as a little-known agency considers a mammoth $31 billion merger.
The DOJ Antitrust Suit Against Google is a Victory for the Washington Monthly
This magazine and, in particular, Phillip Longman, built the intellectual architecture to prosecute the tech giant’s predatory practices.
The Economy is Doing Fine, for the Time Being
Growth is strong but bound to slow as the Fed keeps hiking interest rates. Even better news: The economy could see a nice rebound in 2024.
Unlike AmeriCorps, the California Service Plan Benefits Residents and the Undocumented
The state’s impressive CollegeCorps program aids postsecondary students in exchange for community service.
How to Rein In Elon Musk
The tech titan controls Twitter, Tesla and a vital satellite network, and has too much power. Fortunately, the government has the legal and regulatory authority to constrain him.

